Summary characteristics of ongoing trials of RIC in stroke
Parameter | No of studies | ||
Study population | Ischaemic stroke/TIA | 31 | |
Symptomatic intracranial stenosis | 8 | ||
Aneurysmal subarachnoid haemorrhage | 4 | ||
Unruptured cerebral aneurysm | 3 | ||
Intracerebral haemorrhage | 3 | ||
Timing of conditioning | RIPreC | 3 | |
RIPerC and early RIPostC | 28 | ||
Chronic RIPostC | 16 | ||
Unspecified | 1 | ||
Participants (N) | <100 | 24 | |
100–500 | 17 | ||
501–1000 | 4 | ||
>1000 | 3 | ||
RIC protocol | Cuff pressure | 180 mm Hg | 2 |
200 mm Hg | 26 | ||
225 mm Hg | 2 | ||
20 mm Hg >SBP | 4 | ||
30 mm Hg >SBP | 2 | ||
50 mm Hg >SBP | 1 | ||
110 mm Hg >SBP | 1 | ||
Variable | 1 | ||
Unspecified | 9 | ||
Cycle length | 3 min | 1 | |
5 min | 36 | ||
10 min | 1 | ||
Variable | 1 | ||
Unspecified | 9 | ||
Cycle frequency | 3 | 5 | |
4 | 16 | ||
5 | 19 | ||
Variable | 1 | ||
Unspecified | 7 | ||
Limb | Upper | 36 | |
Lower | 5 | ||
Unspecified | 7 | ||
Unilateral | 18 | ||
Bilateral | 16 | ||
Unspecified | 14 | ||
Study location | Asia | 30 | |
Europe | 10 | ||
North America | 8 | ||
Primary outcome measures | Clinical | modified Rankin Scale | 6 |
Compliance/feasibility | 6 | ||
Adverse events | 6 | ||
Recurrent stroke | 4 | ||
Combined vascular events | 1 | ||
All-cause mortality | 1 | ||
NIHSS | 1 | ||
Walking speed | 1 | ||
Depression incidence | 1 | ||
Blood samples | Serum biomarkers | 5 | |
Immune profile | 2 | ||
Coagulation profile | 1 | ||
Radiological | Infarct size/growth | 6 | |
New infarcts | 2 | ||
Cerebral blood flow/collateral circulation | 3 | ||
Vasospasm | 2 | ||
Flow-mediated dilatation | 1 | ||
Other | P300 event-related potential | 1 | |
Cardiac function (echocardiogram) | 1 | ||
Estimated study completion | 2019 | 11 | |
2020 | 10 | ||
2021 | 8 | ||
2022 | 5 | ||
2023 | 0 | ||
2024 | 3 |
RIC, remote ischaemic conditioning; RIPerC, Remote ischaemic perconditioning; RIPostC, Remote ischaemic postconditioning; RIPreC, Remote ischaemic preconditioning; SBP, systolic blood pressure; TIA, Transient Ischaemic Attack.